Refreshing results…
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma
Download from doi.orgFOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma
Download from www.nature.comMissing publications? Search for publications with a matching author name.